OCLN and spindle cell hemangioma: CTX administration decreased the expression of ZO‐1, Mucin‐2, Occludin, and Claudin‐1, whereas SCH treatment enhanced the extracellular barrier and elevated the expression of tight junction‐associated proteins, as illustrated in Figures 9 and 10.